COVID-19 in solid organ transplant recipients: No difference in survival compared to general population

Area of Science:

• Transplant medicine
• Infectious diseases
• Critical care medicine

Background:

• Solid organ transplant (SOT) recipients may face worse outcomes with COVID-19.
• Understanding COVID-19's impact on SOT recipients is crucial for clinical management.

Purpose of the Study:

• To compare 30-day mortality and clinical outcomes of COVID-19 in SOT recipients versus non-SOT patients.
• To investigate the association between SOT status and mortality after COVID-19 hospitalization.

Main Methods:

• Prospective cohort study of 885 hospitalized COVID-19 patients (24 SOT recipients).
• Comparison of SOT recipients with non-SOT patients regarding demographics, clinical presentation, and outcomes.
• Univariable and multivariable Cox regression analysis to assess 30-day mortality risk.

Main Results:

• No significant difference in 30-day all-cause mortality between SOT recipients (19%) and non-SOT patients (22.1%).
• SOT recipients had a trend towards higher rates of respiratory failure (50% vs 33.1%) and significantly more superinfections (50% vs 15.5%).
• Multivariate analysis showed no association between SOT status and 30-day mortality (HR 1.15, P=0.79).

Conclusions:

• COVID-19 mortality in SOT recipients appears similar to the general hospitalized population.
• SOT recipients experienced higher rates of superinfections and a trend towards increased respiratory failure.
• Clinical vigilance for complications is warranted in SOT recipients with COVID-19.